SERPINA3 and Alzheimer disease: WB analysis of frontal cortex samples from AD patients at early stages of NFT pathology revealed the presence of SERPINA3-chymotrypsin complex, which is consistent with the sum of the molecular weight of human brain expressed SERPINA3 (almost 70 kDa) and chymotrypsin (25 kDa) (Fig. 6a).